Publication | Closed Access

MKK4 is a novel target for the inhibition of tumor necrosis factor-α-induced vascular endothelial growth factor expression by myricetin

InflammationAngiogenesisNovel TargetImmunologyEndothelial DysfunctionPathologyVascular BiologyMedicineCell BiologyCell SignalingTumor Biology